Muramyl dipeptide (MDP) (N-acetylmuramyl-L-alanyl-D-isoglutamine was inject
ed intracamerally to test if MDP applied to the aqueous side of the blood-a
queous barrier would increase paracellular permeability in association with
diminished uptake of glutamate. The symptoms of anterior uveitis, i.e., in
crease in vascular dilatation, could be detected as early as 30 min post MD
P injection while aqueous protein concentration did not increase at this ti
me suggesting an initial dissociation between the circulatory and epithelia
l barrier responses. However, at 45 min, the aqueous protein concentration
increased 10-fold (201+/-174 to 2094+/-1835 mu g ml(-1); P < 0.001) rising
progressively to 20-fold above the control eye at 60 min post injection (25
4+/-194 vs. 5038+/-2514 mu g ml(-1); P < 0.001). Epithelial cell barrier pa
racellular permeability increased at 45 min as evidenced by the enhanced ef
flux of radiolabelled L-glucose out of the aqueous (8% and 13% faster than
control at 45 and 60 min post MDP injection, respectively), coinciding with
the accelerated protein influx. A near 50% reduction in efflux of both rad
iolabelled glutamate and D-aspartate was consistent with reduced glutamate
uptake by the transport system X-AG(-). In addition, a 24% decline in aqueo
us glutamate, but not aspartate, was detected in the aqueous of the MDP-tre
ated eyes in association with a 54% decrease in iris/ciliary body gamma-glu
tamyltranspeptidase activity consistent with reduced de novo glutamate form
ation from glutamine. The aqueous of MDP injected eyes also had 6-fold and
34-fold higher prostaglandin E-2 and F-2 alpha concentrations, respectively
(P less than or equal to 0.03) as well as reduced AH bicarbonate concentra
tion. These results suggest that increased paracellular permeability is ass
ociated with diminished gamma-glutamyltranspepidase-mediated glutamate prod
uction, X-AG(-) transport activity, and cellular acidosis in the MDP-induce
d prostaglandin-mediated inflammation. (C) 1999 Academic Press.